Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis.
Saved in:
| Title: | Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis. |
|---|---|
| Authors: | Dhakal, B1, D'Souza, A1, Arce-Lara, C1, Pasquini, M1, Saber, W1, Falvo, F1, Esselman, J1, Zellner, K1, Fenske, T1, Hari, P N1, Hamadani, M1 |
| Source: | Bone Marrow Transplantation. Apr2015, Vol. 50 Issue 4, p610-612. 3p. |
| Database: | Academic Search Ultimate |
| ISSN: | 02683369 |
|---|---|
| DOI: | 10.1038/bmt.2014.318 |